{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AP1", "FLI1", "HSPA1B", "Leukemia proliferation", "Oncogene", "SYK", "Transcriptional regulation", "Tumor suppressor", "UBASH3A", "UBASH3B"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38461240", "DateCompleted": {"Year": "2024", "Month": "03", "Day": "11"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "28"}, "Article": {"Language": ["eng"], "ELocationID": ["326", "10.1186/s12885-024-12075-2"], "ArticleDate": [{"Year": "2024", "Month": "03", "Day": "09"}], "Journal": {"ISSN": "1471-2407", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Mar", "Day": "09"}}, "Title": "BMC cancer", "ISOAbbreviation": "BMC Cancer"}, "ArticleTitle": "FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.", "Pagination": {"StartPage": "326", "MedlinePgn": "326"}, "Abstract": {"AbstractText": ["FLI1 is an oncogenic transcription factor that promotes diverse malignancies through mechanisms that are not fully understood. Herein, FLI1 is shown to regulate the expression of Ubiquitin Associated and SH3 Domain Containing A/B (UBASH3A/B) genes. UBASH3B and UBASH3A are found to act as an oncogene and tumor suppressor, respectively, and their combined effect determines erythroleukemia progression downstream of FLI1.", "Promoter analysis combined with luciferase assays and chromatin immunoprecipitation (ChIP) analysis were applied on the UBASH3A/B promoters. RNAseq analysis combined with bioinformatic was used to determine the effect of knocking-down UBASH3A and UBASH3B in leukemic cells. Downstream targets of UBASH3A/B were inhibited in leukemic cells either via lentivirus-shRNAs or small molecule inhibitors. Western blotting and RT-qPCR were used to determine transcription levels, MTT assays to assess proliferation rate, and flow cytometry to examine apoptotic index.", "Knockdown of FLI1 in erythroleukemic cells identified the UBASH3A/B genes as potential downstream targets. Herein, we show that FLI1 directly binds to the UBASH3B promoter, leading to its activation and leukemic cell proliferation. In contrast, FLI1 indirectly inhibits UBASH3A transcription via GATA2, thereby antagonizing leukemic growth. These results suggest oncogenic and tumor suppressor roles for UBASH3B and UBASH3A in erythroleukemia, respectively. Mechanistically, we show that UBASH3B indirectly inhibits AP1 (FOS and JUN) expression, and that its loss leads to inhibition of apoptosis and acceleration of proliferation. UBASH3B also positively regulates the SYK gene expression and its inhibition suppresses leukemia progression. High expression of UBASH3B in diverse tumors was associated with worse prognosis. In contrast, UBASH3A knockdown in erythroleukemic cells increased proliferation; and this was associated with a dramatic induction of the HSP70 gene, HSPA1B. Accordingly, knockdown of HSPA1B in erythroleukemia cells significantly accelerated leukemic cell proliferation. Accordingly, overexpression of UBASH3A in different cancers was predominantly associated with good prognosis. These results suggest for the first time that UBASH3A plays a tumor suppressor role in part through activation of HSPA1B.", "FLI1 promotes erythroleukemia progression in part by modulating expression of the oncogenic UBASH3B and tumor suppressor UBASH3A."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang-550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, High Tech Zone, Province Science City, Baiyun District, Guiyang, 550014, China."}], "LastName": "Wang", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang-550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, High Tech Zone, Province Science City, Baiyun District, Guiyang, 550014, China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang-550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, High Tech Zone, Province Science City, Baiyun District, Guiyang, 550014, China."}], "LastName": "Hu", "ForeName": "Anling", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang-550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, High Tech Zone, Province Science City, Baiyun District, Guiyang, 550014, China."}], "LastName": "Yu", "ForeName": "Kunlin", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang-550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, High Tech Zone, Province Science City, Baiyun District, Guiyang, 550014, China."}], "LastName": "Kuang", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang-550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guizhou Province, Guiyang, 550025, People's Republic of China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, ON, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute, University Health Network, Toronto, ON, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "eBond Pharmaceutical Technology Ltd, Chengdu, Sichuan, People's Republic of China."}], "LastName": "Sample", "ForeName": "Klarke Michael", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang-550014, Guizhou, People's Republic of China."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, High Tech Zone, Province Science City, Baiyun District, Guiyang, 550014, China."}], "LastName": "Xiao", "ForeName": "Xiao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang-550014, Guizhou, People's Republic of China. emmalao@163.com."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, High Tech Zone, Province Science City, Baiyun District, Guiyang, 550014, China. emmalao@163.com."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang-550014, Guizhou, People's Republic of China. yaacovbendavid@hotmail.com."}, {"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, High Tech Zone, Province Science City, Baiyun District, Guiyang, 550014, China. yaacovbendavid@hotmail.com."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "GrantList": [{"GrantID": "QKHJC-ZK [2022] YB297, QKHJC-ZK [2023] YB240", "Agency": "the Science and Technology Department of Guizhou Province grants", "Country": ""}, {"GrantID": "QKHJC-ZK [2022] YB297, QKHJC-ZK [2023] YB240", "Agency": "the Science and Technology Department of Guizhou Province grants", "Country": ""}, {"GrantID": "RN21025", "Agency": "the Guizhou Medical University Research Grant", "Country": ""}, {"GrantID": "GZCNP202203Z", "Agency": "the Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences Research Grant", "Country": ""}, {"GrantID": "U1812403, 21867009, and 82260040", "Agency": "National Natural Science Foundation of China", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Cancer", "NlmUniqueID": "100967800", "ISSNLinking": "1471-2407"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adaptor Proteins, Signal Transducing"}, {"RegistryNumber": "0", "NameOfSubstance": "Oncogene Proteins, Fusion"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Protein c-fli-1"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Small Interfering"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA-Binding Protein EWS"}, {"RegistryNumber": "0", "NameOfSubstance": "UBASH3A protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "FLI1 protein, human"}, {"RegistryNumber": "EC 3.1.3.48", "NameOfSubstance": "UBASH3B protein, human"}, {"RegistryNumber": "EC 3.1.3.48", "NameOfSubstance": "Protein Tyrosine Phosphatases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Adaptor Proteins, Signal Transducing"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Genes, Tumor Suppressor"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Leukemia, Erythroblastic, Acute"}, {"QualifierName": ["genetics"], "DescriptorName": "Oncogene Proteins, Fusion"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Proto-Oncogene Protein c-fli-1"}, {"QualifierName": ["genetics"], "DescriptorName": "RNA, Small Interfering"}, {"QualifierName": ["genetics"], "DescriptorName": "RNA-Binding Protein EWS"}, {"QualifierName": ["metabolism"], "DescriptorName": "Protein Tyrosine Phosphatases"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Tsygankov AY. TULA proteins in men, mice, hens, and lice: welcome to the family. Int J Mol Sci. 2023;24(11):9126. doi: 10.3390/ijms24119126.", "ArticleIdList": ["10.3390/ijms24119126", "PMC10253181", "37298079"]}, {"Citation": "Carpino N, Turner S, Mekala D, Takahashi Y, Zang H, Geiger TL, Doherty P, Ihle JN. Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity. 2004;20(1):37\u201346. doi: 10.1016/S1074-7613(03)00351-0.", "ArticleIdList": ["10.1016/S1074-7613(03)00351-0", "14738763"]}, {"Citation": "Carpino N, Kobayashi R, Zang H, Takahashi Y, Jou ST, Feng J, Nakajima H, Ihle JN. Identification, cDNA cloning, and targeted deletion of p70, a novel, ubiquitously expressed SH3 domain-containing protein. Mol Cell Biol. 2002;22(21):7491\u20137500. doi: 10.1128/MCB.22.21.7491-7500.2002.", "ArticleIdList": ["10.1128/MCB.22.21.7491-7500.2002", "PMC135669", "12370296"]}, {"Citation": "San Luis B, Sondgeroth B, Nassar N, Carpino N. Sts-2 is a phosphatase that negatively regulates zeta-associated protein (ZAP)-70 and T cell receptor signaling pathways. J Biol Chem. 2011;286(18):15943\u201315954. doi: 10.1074/jbc.M110.177634.", "ArticleIdList": ["10.1074/jbc.M110.177634", "PMC3091203", "21393235"]}, {"Citation": "Concannon P, Onengut-Gumuscu S, Todd JA, Smyth DJ, Pociot F, Bergholdt R, Akolkar B, Erlich HA, Hilner JE, Julier C, et al. A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes. 2008;57(10):2858\u20132861. doi: 10.2337/db08-0753.", "ArticleIdList": ["10.2337/db08-0753", "PMC2551699", "18647951"]}, {"Citation": "Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med. 2008;359(26):2767\u20132777. doi: 10.1056/NEJMoa0807917.", "ArticleIdList": ["10.1056/NEJMoa0807917", "PMC2840835", "19073967"]}, {"Citation": "Zhernakova A, Stahl EA, Trynka G, Raychaudhuri S, Festen EA, Franke L, Westra HJ, Fehrmann RS, Kurreeman FA, Thomson B, et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 2011;7(2):e1002004. doi: 10.1371/journal.pgen.1002004.", "ArticleIdList": ["10.1371/journal.pgen.1002004", "PMC3044685", "21383967"]}, {"Citation": "Chen YG, Ciecko AE, Khaja S, Grzybowski M, Geurts AM, Lieberman SM. UBASH3A deficiency accelerates type 1 diabetes development and enhances salivary gland inflammation in NOD mice. Sci Rep. 2020;10(1):12019. doi: 10.1038/s41598-020-68956-6.", "ArticleIdList": ["10.1038/s41598-020-68956-6", "PMC7374577", "32694640"]}, {"Citation": "Hoeller D, Crosetto N, Blagoev B, Raiborg C, Tikkanen R, Wagner S, Kowanetz K, Breitling R, Mann M, Stenmark H, et al. Regulation of ubiquitin-binding proteins by monoubiquitination. Nat Cell Biol. 2006;8(2):163\u2013169. doi: 10.1038/ncb1354.", "ArticleIdList": ["10.1038/ncb1354", "16429130"]}, {"Citation": "Bertelsen V, Breen K, Sandvig K, Stang E, Madshus IH. The Cbl-interacting protein TULA inhibits dynamin-dependent endocytosis. Exp Cell Res. 2007;313(8):1696\u20131709. doi: 10.1016/j.yexcr.2007.02.017.", "ArticleIdList": ["10.1016/j.yexcr.2007.02.017", "17382318"]}, {"Citation": "Feshchenko EA, Smirnova EV, Swaminathan G, Teckchandani AM, Agrawal R, Band H, Zhang X, Annan RS, Carr SA, Tsygankov AY. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin. Oncogene. 2004;23(27):4690\u20134706. doi: 10.1038/sj.onc.1207627.", "ArticleIdList": ["10.1038/sj.onc.1207627", "15107835"]}, {"Citation": "Wattenhofer M, Shibuya K, Kudoh J, Lyle R, Michaud J, Rossier C, Kawasaki K, Asakawa S, Minoshima S, Berry A, et al. Isolation and characterization of the UBASH3A gene on 21q22.3 encoding a potential nuclear protein with a novel combination of domains. Hum Genet. 2001;108(2):140\u2013147. doi: 10.1007/s004390000453.", "ArticleIdList": ["10.1007/s004390000453", "11281453"]}, {"Citation": "Chen Y, Jakoncic J, Carpino N, Nassar N. Structural and functional characterization of the 2H-phosphatase domain of Sts-2 reveals an acid-dependent phosphatase activity. Biochemistry. 2009;48(8):1681\u20131690. doi: 10.1021/bi802219n.", "ArticleIdList": ["10.1021/bi802219n", "PMC2880635", "19196006"]}, {"Citation": "Mikhailik A, Ford B, Keller J, Chen Y, Nassar N, Carpino N. A phosphatase activity of Sts-1 contributes to the suppression of TCR signaling. Mol Cell. 2007;27(3):486\u2013497. doi: 10.1016/j.molcel.2007.06.015.", "ArticleIdList": ["10.1016/j.molcel.2007.06.015", "PMC2709417", "17679096"]}, {"Citation": "Chen X, Ren L, Kim S, Carpino N, Daniel JL, Kunapuli SP, Tsygankov AY, Pei D. Determination of the substrate specificity of protein-tyrosine phosphatase TULA-2 and identification of Syk as a TULA-2 substrate. J Biol Chem. 2010;285(41):31268\u201331276. doi: 10.1074/jbc.M110.114181.", "ArticleIdList": ["10.1074/jbc.M110.114181", "PMC2951201", "20670933"]}, {"Citation": "Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, Chen J, Whitman SP, Bloomfield CD, Nicolet D, et al. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO. Leukemia. 2016;30(3):728\u2013739. doi: 10.1038/leu.2015.275.", "ArticleIdList": ["10.1038/leu.2015.275", "PMC4775400", "26449661"]}, {"Citation": "Lee ST, Feng M, Wei Y, Li Z, Qiao Y, Guan P, Jiang X, Wong CH, Huynh K, Wang J, et al. Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis. Proc Natl Acad Sci U S A. 2013;110(27):11121\u201311126. doi: 10.1073/pnas.1300873110.", "ArticleIdList": ["10.1073/pnas.1300873110", "PMC3704014", "23784775"]}, {"Citation": "Yao Y, Liu W, Gajendran B, Wang C, Zacksenhaus E, Sample KM, Varier KM, Hao X, Ben-David Y. Ubash3b promotes TPA-mediated suppression of leukemogenesis through accelerated downregulation of PKCdelta protein. Biochimie. 2021;184:8\u201317. doi: 10.1016/j.biochi.2021.02.001.", "ArticleIdList": ["10.1016/j.biochi.2021.02.001", "33556471"]}, {"Citation": "Asano Y, Trojanowska M. Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta. Mol Cell Biol. 2009;29(7):1882\u20131894. doi: 10.1128/MCB.01320-08.", "ArticleIdList": ["10.1128/MCB.01320-08", "PMC2655609", "19158279"]}, {"Citation": "Li YJ, Zhao X, Vecchiarelli-Federico LM, Li Y, Datti A, Cheng Y, Ben-David Y. Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J. 2012;2(1):e54. doi: 10.1038/bcj.2011.52.", "ArticleIdList": ["10.1038/bcj.2011.52", "PMC3270256", "22829238"]}, {"Citation": "Liu T, Yao Y, Zhang G, Wang Y, Deng B, Song J, Li X, Han F, Xiao X, Yang J, et al. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis. Oncotarget. 2017;8(10):16728\u201316743. doi: 10.18632/oncotarget.14377.", "ArticleIdList": ["10.18632/oncotarget.14377", "PMC5369997", "28052010"]}, {"Citation": "Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci U S A. 1990;87(4):1332\u20131336. doi: 10.1073/pnas.87.4.1332.", "ArticleIdList": ["10.1073/pnas.87.4.1332", "PMC53469", "2304901"]}, {"Citation": "Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5(6):908\u2013918. doi: 10.1101/gad.5.6.908.", "ArticleIdList": ["10.1101/gad.5.6.908", "2044959"]}, {"Citation": "Azimi A, Tuominen R, Costa Svedman F, Caramuta S, Pernemalm M, Frostvik Stolt M, Kanter L, Kharaziha P, Lehtio J, Hertzman Johansson C, et al. Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells. Cell Death Dis. 2017;8(8):e3029. doi: 10.1038/cddis.2017.406.", "ArticleIdList": ["10.1038/cddis.2017.406", "PMC5596587", "29048432"]}, {"Citation": "Bonetti P, Testoni M, Scandurra M, Ponzoni M, Piva R, Mensah AA, Rinaldi A, Kwee I, Tibiletti MG, Iqbal J, et al. Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. Blood. 2013;122(13):2233\u20132241. doi: 10.1182/blood-2013-01-475772.", "ArticleIdList": ["10.1182/blood-2013-01-475772", "23926301"]}, {"Citation": "Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang S, Song W, Li X, Li L, Du Z, et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol. 2018;19(1):218. doi: 10.1186/s13059-018-1594-y.", "ArticleIdList": ["10.1186/s13059-018-1594-y", "PMC6290540", "30537986"]}, {"Citation": "Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359(6391):162\u2013165. doi: 10.1038/359162a0.", "ArticleIdList": ["10.1038/359162a0", "1522903"]}, {"Citation": "Kornblau SM, Qiu YH, Zhang N, Singh N, Faderl S, Ferrajoli A, York H, Qutub AA, Coombes KR, Watson DK. Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood. 2011;118(20):5604\u20135612. doi: 10.1182/blood-2011-04-348052.", "ArticleIdList": ["10.1182/blood-2011-04-348052", "PMC3217360", "21917756"]}, {"Citation": "Liu T, Xia L, Yao Y, Yan C, Fan Y, Gajendran B, Yang J, Li YJ, Chen J, Filmus J, et al. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis. 2019;10(2):117. doi: 10.1038/s41419-019-1363-1.", "ArticleIdList": ["10.1038/s41419-019-1363-1", "PMC6370842", "30741932"]}, {"Citation": "Mhawech-Fauceglia P, Herrmann FR, Bshara W, Odunsi K, Terracciano L, Sauter G, Cheney RT, Groth J, Penetrante R, Mhawech-Fauceglia P. Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. J Clin Pathol. 2007;60(6):694\u2013700. doi: 10.1136/jcp.2006.039230.", "ArticleIdList": ["10.1136/jcp.2006.039230", "PMC1955051", "16917000"]}, {"Citation": "Sakurai T, Kondoh N, Arai M, Hamada J, Yamada T, Kihara-Negishi F, Izawa T, Ohno H, Yamamoto M, Oikawa T. Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy. Cancer Sci. 2007;98(11):1775\u20131784. doi: 10.1111/j.1349-7006.2007.00598.x.", "ArticleIdList": ["10.1111/j.1349-7006.2007.00598.x", "17727680"]}, {"Citation": "Scheiber MN, Watson PM, Rumboldt T, Stanley C, Wilson RC, Findlay VJ, Anderson PE, Watson DK. FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia (New York, NY) 2014;16(10):801\u2013813. doi: 10.1016/j.neo.2014.08.007.", "ArticleIdList": ["10.1016/j.neo.2014.08.007", "PMC4212256", "25379017"]}, {"Citation": "Smeets MF, Chan AC, Dagger S, Bradley CK, Wei A, Izon DJ. Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia/lymphoma. PLoS ONE. 2013;8(5):e62346. doi: 10.1371/journal.pone.0062346.", "ArticleIdList": ["10.1371/journal.pone.0062346", "PMC3646842", "23667468"]}, {"Citation": "Song W, Li W, Li L, Zhang S, Yan X, Wen X, Zhang X, Tian H, Li A, Hu JF, et al. Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer. Oncotarget. 2015;6(27):23764\u201323775. doi: 10.18632/oncotarget.4350.", "ArticleIdList": ["10.18632/oncotarget.4350", "PMC4695150", "26156017"]}, {"Citation": "Torlakovic EE, Slipicevic A, Florenes VA, Chibbar R, DeCoteau JF, Bilalovic N. Fli-1 expression in malignant melanoma. Histol Histopathol. 2008;23(11):1309\u20131314.", "ArticleIdList": ["18785112"]}, {"Citation": "Yan X, Yu Y, Li L, Chen N, Song W, He H, Dong J, Liu X, Cui J. Friend leukemia virus integration 1 is a predictor of poor prognosis of breast cancer and promotes metastasis and cancer stem cell properties of breast cancer cells. Cancer Med. 2018;7(8):3548\u20133560. doi: 10.1002/cam4.1589.", "ArticleIdList": ["10.1002/cam4.1589", "PMC6089157", "29869379"]}, {"Citation": "Ben-David Y, Gajendran B, Sample KM, Zacksenhaus E. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. Cell Mol Life Sci. 2022;79(3):163. doi: 10.1007/s00018-022-04160-1.", "ArticleIdList": ["10.1007/s00018-022-04160-1", "35412146"]}, {"Citation": "Wang C, Sample KM, Gajendran B, Kapranov P, Liu W, Hu A, Zacksenhaus E, Li Y, Hao X, Ben-David Y. FLI1 induces megakaryopoiesis gene expression through WAS/WIP-dependent and independent mechanisms; implications for Wiskott-Aldrich syndrome. Front Immunol. 2021;12:607836. doi: 10.3389/fimmu.2021.607836.", "ArticleIdList": ["10.3389/fimmu.2021.607836", "PMC7953068", "33717090"]}, {"Citation": "Sloan CA, Chan ET, Davidson JM, Malladi VS, Strattan JS, Hitz BC, Gabdank I, Narayanan AK, Ho M, Lee BT, et al. ENCODE data at the ENCODE portal. Nucleic Acids Res. 2016;44(D1):D726\u2013732. doi: 10.1093/nar/gkv1160.", "ArticleIdList": ["10.1093/nar/gkv1160", "PMC4702836", "26527727"]}, {"Citation": "Motomura H, Seki S, Shiozawa S, Aikawa Y, Nogami M, Kimura T. A selective c-Fos/AP-1 inhibitor prevents cartilage destruction and subsequent osteophyte formation. Biochem Biophys Res Commun. 2018;497(2):756\u2013761. doi: 10.1016/j.bbrc.2018.02.147.", "ArticleIdList": ["10.1016/j.bbrc.2018.02.147", "29476740"]}, {"Citation": "Wang X, Oates JC, Helke KL, Gilkeson GS, Zhang XK. Camptothecin and topotecan, inhibitors of transcription factor fli-1 and topoisomerase, markedly ameliorate lupus nephritis in (NZB x NZW)F1 mice and reduce the production of inflammatory mediators in human renal cells. Arthritis Rheumatol. 2021;73(8):1478\u20131488. doi: 10.1002/art.41685.", "ArticleIdList": ["10.1002/art.41685", "PMC9853877", "33559345"]}, {"Citation": "Schutt SD, Wu Y, Kharel A, Bastian D, Choi HJ, Hanief Sofi M, Mealer C, McDaniel Mims B, Nguyen H, Liu C, et al. The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease. J Clin Invest. 2022;132(21):e143950. doi: 10.1172/JCI143950.", "ArticleIdList": ["10.1172/JCI143950", "PMC9621143", "36074578"]}, {"Citation": "Leveille E, Chan LN, Mirza AS, Kume K, M\u00fcschen M. SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies. Cell Signal. 2022;94:110331. doi: 10.1016/j.cellsig.2022.110331.", "ArticleIdList": ["10.1016/j.cellsig.2022.110331", "35398488"]}, {"Citation": "Sun S, Xue D, Chen Z, Ou-Yang Y, Zhang J, Mai J, Gu J, Lu W, Liu X, Liu W, et al. R406 elicits anti-warburg effect via syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells. Cell Death Dis. 2019;10(5):358. doi: 10.1038/s41419-019-1587-0.", "ArticleIdList": ["10.1038/s41419-019-1587-0", "PMC6494878", "31043589"]}, {"Citation": "Chen B, Sheng D, Wang C, Liu W, Hu A, Xiao X, Gajendran B, Gao J, Hu J, Sample KM, et al. FLI1 regulates inflammation-associated genes to accelerate leukemogenesis. Cell Signal. 2022;92:110269. doi: 10.1016/j.cellsig.2022.110269.", "ArticleIdList": ["10.1016/j.cellsig.2022.110269", "35104574"]}, {"Citation": "Song D, Lian Y, Zhang L. The potential of activator protein 1 (AP-1) in cancer targeted therapy. Front Immunol. 2023;14:1224892. doi: 10.3389/fimmu.2023.1224892.", "ArticleIdList": ["10.3389/fimmu.2023.1224892", "PMC10361657", "37483616"]}, {"Citation": "Shaulian E. AP-1\u2013The Jun proteins: Oncogenes or tumor suppressors in disguise? Cell Signal. 2010;22(6):894\u2013899. doi: 10.1016/j.cellsig.2009.12.008.", "ArticleIdList": ["10.1016/j.cellsig.2009.12.008", "20060892"]}, {"Citation": "Somervaille TC, Cleary ML. PU.1 and Junb: suppressing the formation of acute myeloid leukemia stem cells. Cancer Cell. 2006;10(6):456\u2013457. doi: 10.1016/j.ccr.2006.11.009.", "ArticleIdList": ["10.1016/j.ccr.2006.11.009", "17157786"]}, {"Citation": "Guan Y, Zhu X, Liang J, Wei M, Huang S, Pan X. Upregulation of HSPA1A/HSPA1B/HSPA7 and downregulation of HSPA9 were related to poor survival in colon cancer. Front Oncol. 2021;11:749673. doi: 10.3389/fonc.2021.749673.", "ArticleIdList": ["10.3389/fonc.2021.749673", "PMC8576338", "34765552"]}]}], "History": [{"Year": "2023", "Month": "7", "Day": "21"}, {"Year": "2024", "Month": "3", "Day": "1"}, {"Year": "2024", "Month": "3", "Day": "11", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "3", "Day": "10", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "3", "Day": "9", "Hour": "23", "Minute": "13"}, {"Year": "2024", "Month": "3", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["38461240", "PMC10925000", "10.1186/s12885-024-12075-2", "10.1186/s12885-024-12075-2"]}}]}